Novanta (NASDAQ:NOVT) Announces FY 2026 Earnings Guidance

Novanta (NASDAQ:NOVT) updated its FY 2026 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 3.660-3.710 for the period, compared to the consensus estimate of 3.690. The company issued revenue guidance of $1.1 billion, compared to the consensus revenue estimate of $1.1 billion. Novanta also updated its Q4 2026 guidance to 0.910-0.960 EPS.

Novanta Stock Performance

Shares of NOVT stock opened at $123.31 on Thursday. The stock has a market capitalization of $4.66 billion, a price-to-earnings ratio of 94.13 and a beta of 1.71. Novanta has a one year low of $98.27 and a one year high of $176.38. The company’s 50-day simple moving average is $141.40 and its 200-day simple moving average is $142.45. The company has a debt-to-equity ratio of 0.48, a quick ratio of 3.79 and a current ratio of 1.18.

Novanta (NASDAQ:NOVT) last issued its earnings results on Monday, November 9th. The technology company reported $1.05 earnings per share for the quarter, topping analysts’ consensus estimates of $0.97 by $0.08. Novanta had a net margin of 4.89% and a return on equity of 10.23%. The company had revenue of $305.01 million for the quarter, compared to analysts’ expectations of $301.02 million. During the same period in the prior year, the company earned $0.87 earnings per share. The firm’s revenue was up 23.1% compared to the same quarter last year. Equities analysts anticipate that Novanta will post 3.70 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have commented on the stock. Zacks Research cut shares of Novanta from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 6th. Weiss Ratings lowered shares of Novanta from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Tuesday. Robert W. Baird reduced their price target on shares of Novanta from $194.00 to $175.00 and set an “outperform” rating for the company in a research note on Thursday. Finally, Wall Street Zen upgraded shares of Novanta from a “hold” rating to a “buy” rating in a report on Saturday, November 7th. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $175.00.

Novanta Company Profile

Novanta develops and manufactures precision technologies used in medical and advanced industrial applications. Its products include photonics and laser components, precision motion-control systems, machine-vision technologies, and related equipment and software. The company’s technologies are used in areas such as medical and surgical systems, life sciences, robotics, and industrial automation. Novanta serves customers internationally, with operations and customers across North America, Europe, and Asia.